Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis.
Andrea SagliettoFabrizio D'AscenzoDaniele ErrigoSergio LeonardiWillem J DewildeFederico ConrottoPierluigi OmedèAntonio MontefuscoFilippo AngeliniOvidio De FilippoMatteo BiancoGuglielmo GalloneFrancesco BrunoLorenzo ZaccaroFrancesco GianniniAzeem LatibAntonio ColomboFrancesco CostaGaetano Maria De FerrariPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
DAT regimens present the highest safety profile among antithrombotic strategies, with a NOAC-specific impact on ICH reduction. NOAC DAT might entail clinically important higher ST occurrence, warranting a case-by-case comprehensive evaluation that integrates patient- and procedure-related residual ischemic risk with the patient-specific bleeding risk.
Keyphrases
- atrial fibrillation
- percutaneous coronary intervention
- oral anticoagulants
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- coronary artery disease
- acute coronary syndrome
- st segment elevation myocardial infarction
- risk assessment
- case report
- acute myocardial infarction
- prognostic factors
- venous thromboembolism
- antiplatelet therapy
- heart failure
- ischemia reperfusion injury
- st elevation myocardial infarction
- coronary artery bypass grafting
- oxidative stress
- blood brain barrier
- brain injury
- left ventricular